Re-Imagining the Life Sciences & Research: A New Disruptive Women in Health Care Series

When I think of the value of the Precision Medicine Initiative that President Obama announced earlier this year, the money involved isn’t the first thing that comes to mind (although over $200 million in proposed dollars to entities like the National Institutes of Health (NIH) and the National Cancer Institute are worth cheering).  Actually, the focus on precision medicine provides a tremendous opportunity to take a step back and consider the future of research, medicine and the life sciences. That’s exactly what we’re going to be doing over the next several days here in the Disruptive Women in Health Care space.   Experts from a variety of health related sectors and with diverse perspectives are going to be sharing their views on “Re-Imagining the Life Sciences and Research.”  We need discussions like this because, while the potential in this field is truly breathtaking and difficult to fully comprehend, there are critical unanswered questions. Precision medicine presents an excellent example of how far we’ve come in the research arena.  It was only a few years ago that there were just a handful of researchers and clinicians figuring out how to use genetics to design targeted disease treatments and therapies.  Now, increased data mining capabilities and more affordable human genome sequencing are making it possible to imagine cures for diseases that were once, and in many cases still are, deemed death sentences. But with the early stages of progress comes q...
Source: Disruptive Women in Health Care - Category: Consumer Health News Authors: Tags: Chronic Conditions Genetics Innovation Source Type: blogs